{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 22,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/7",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "chart",
      "text": "Projected sales of gene-modified cell therapies by 2026",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebcc3259-7c50-4a4f-99f4-17ad6e0121bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.35,
        "x": 0.6,
        "y": 0.48
      },
      "kind": "list",
      "text": "2022 was focused on innovation and complexity: \"Other\" cell types grew 129% in 2022; Development of allogeneic therapies increased 33%; Rapid growth in cell targets.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41e0ee47-67ae-4176-a366-14c66047ceae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.05,
        "x": 0.52,
        "y": 0.18
      },
      "kind": "metric",
      "text": "6",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1acdf444-aab1-4004-afbd-fdb75396c9e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.12,
        "x": 0.08,
        "y": 0.18
      },
      "kind": "metric",
      "text": "1,800+",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "459de812-f9ad-4d1b-8011-096e3368baa6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.12,
        "x": 0.74,
        "y": 0.28
      },
      "kind": "metric",
      "text": "$12.6B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55757b12-b632-40da-8b32-e8490ab6a58c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.12,
        "x": 0.3,
        "y": 0.18
      },
      "kind": "metric",
      "text": "650+",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bf9a6ef-19f8-470a-9ccc-f7f67df6b3dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.26,
        "x": 0.67,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Total amount of 2022 global financings for cell and gene therapy companies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "062f8125-e646-49ba-beed-278cc19d87b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.16,
        "x": 0.06,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Genetically-modified cell therapies in development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2dd51f06-775a-4e8b-a380-9c9e5f168841",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.2,
        "x": 0.26,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Genetically-modified cell therapies in preclinical development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c0faa98-ec21-4f56-b678-c361511b47fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.14,
        "x": 0.48,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "New cell and gene therapies approved in 2022",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da59f1be-93ab-4cc9-87a3-8f83902126bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Continued Investment in Cell and Gene Therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9a55d56-fb5f-4383-8ca3-be521db569f6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Big Idea Formula",
      "slug": "big-idea-formula",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f6e6a2b3-964b-44a8-9bb1-0521a4c9675c",
      "evidence": "The slide mentions 'Continued Investment in Cell and Gene Therapy' and provides various statistics, which could be part of a big idea formula.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "0c02edbf-888a-429c-abca-50d5703edb41",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Market sizing is discussed on page 7",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    },
    {
      "to": 11,
      "from": 6,
      "beatId": "d4f7f81d-15bd-4167-9e08-bd7e1ed530d3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "The business model is explained on pages 6 and 10-11",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}